{"transactions":[{"id":743653,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:43:25.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020213","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020213/rdgdoc.xml","form_type":"4"}},{"id":1101915,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:01:02.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021270","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021270/rdgdoc.xml","form_type":"4"}},{"id":1479591,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:22:41.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020411","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020411/rdgdoc.xml","form_type":"4"}},{"id":1780419,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:52:19.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":6450,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001437749-23-026072","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026072/rdgdoc.xml","form_type":"4"}},{"id":1787730,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-09-06T20:31:04.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":false,"shares":122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":122},"source":{"system":"sec-edgar","filing":"0001437749-23-025311","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923025311/rdgdoc.xml","form_type":"4"}},{"id":1787729,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-06T20:31:04.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."}],"balance_after":898,"source":{"system":"sec-edgar","filing":"0001437749-23-025311","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923025311/rdgdoc.xml","form_type":"4"}},{"id":1787728,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-06T20:31:04.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":true,"shares":122,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."}],"balance_after":943,"source":{"system":"sec-edgar","filing":"0001437749-23-025311","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923025311/rdgdoc.xml","form_type":"4"}},{"id":1870661,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T21:00:28.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":false,"shares":183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":183,"derivative":{"underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001437749-23-016502","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923016502/rdgdoc.xml","form_type":"4"}},{"id":1870660,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-02T21:00:28.000Z","date":"2023-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1231,"source":{"system":"sec-edgar","filing":"0001437749-23-016502","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923016502/rdgdoc.xml","form_type":"4"}},{"id":1870659,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-02T21:00:28.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":true,"shares":183,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1299,"source":{"system":"sec-edgar","filing":"0001437749-23-016502","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923016502/rdgdoc.xml","form_type":"4"}},{"id":1975469,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-03-03T23:20:25.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":366,"derivative":{"underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001437749-23-005435","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923005435/rdgdoc.xml","form_type":"4"}},{"id":1975468,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-03T23:20:25.000Z","date":"2023-02-28","kind":"disposition_to_issuer","acquired":false,"shares":68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1116,"source":{"system":"sec-edgar","filing":"0001437749-23-005435","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923005435/rdgdoc.xml","form_type":"4"}},{"id":1975467,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-03T23:20:25.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":183,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1184,"source":{"system":"sec-edgar","filing":"0001437749-23-005435","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923005435/rdgdoc.xml","form_type":"4"}},{"id":2098815,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2022-12-03T00:09:22.000Z","date":"2022-11-30","kind":"exercise","acquired":false,"shares":183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On November 30, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 30, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On November 30, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":549,"derivative":{"underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001437749-22-028356","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922028356/rdgdoc.xml","form_type":"4"}},{"id":2098814,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-03T00:09:22.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 30, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 30, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1001,"source":{"system":"sec-edgar","filing":"0001437749-22-028356","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922028356/rdgdoc.xml","form_type":"4"}},{"id":2098813,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-03T00:09:22.000Z","date":"2022-11-30","kind":"exercise","acquired":true,"shares":183,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 30, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1069,"source":{"system":"sec-edgar","filing":"0001437749-22-028356","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922028356/rdgdoc.xml","form_type":"4"}},{"id":2167967,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2022-09-03T01:06:11.000Z","date":"2022-08-31","kind":"exercise","acquired":false,"shares":183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":732,"derivative":{"underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001437749-22-021841","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922021841/rdgdoc.xml","form_type":"4"}},{"id":2167966,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-03T01:06:11.000Z","date":"2022-08-31","kind":"disposition_to_issuer","acquired":false,"shares":67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":886,"source":{"system":"sec-edgar","filing":"0001437749-22-021841","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922021841/rdgdoc.xml","form_type":"4"}},{"id":2167965,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-03T01:06:11.000Z","date":"2022-08-31","kind":"exercise","acquired":true,"shares":183,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":954,"source":{"system":"sec-edgar","filing":"0001437749-22-021841","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922021841/rdgdoc.xml","form_type":"4"}},{"id":2248031,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2022-06-03T00:37:32.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":915,"derivative":{"underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001437749-22-014181","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922014181/rdgdoc.xml","form_type":"4"}},{"id":2248030,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-03T00:37:32.000Z","date":"2022-05-31","kind":"disposition_to_issuer","acquired":false,"shares":67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":771,"source":{"system":"sec-edgar","filing":"0001437749-22-014181","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922014181/rdgdoc.xml","form_type":"4"}},{"id":2248029,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-03T00:37:32.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":183,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":838,"source":{"system":"sec-edgar","filing":"0001437749-22-014181","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922014181/rdgdoc.xml","form_type":"4"}},{"id":2641852,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-07T01:42:35.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":83300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021."}],"balance_after":83300,"derivative":{"exercise_price":0.72,"expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":83300},"source":{"system":"sec-edgar","filing":"0001437749-21-016512","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774921016512/rdgdoc.xml","form_type":"4"}},{"id":2710778,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-17T20:27:42.000Z","date":"2021-05-13","kind":"purchase","acquired":true,"shares":32786,"price":0.61,"value":19999.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6097 to $0.6141, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range."}],"balance_after":32786,"source":{"system":"sec-edgar","filing":"0001437749-21-012537","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774921012537/rdgdoc.xml","form_type":"4"}},{"id":3018806,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2020-10-02T00:29:21.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":54900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"2.\tEach restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"3.\tThe shares underlying the restricted stock units will vest in 6 equal (or as nearly equal as possible) quarterly installments on the last calendar day of each quarter over an 18-month period beginning on March 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"3.\tThe shares underlying the restricted stock units will vest in 6 equal (or as nearly equal as possible) quarterly installments on the last calendar day of each quarter over an 18-month period beginning on March 1, 2022."}],"balance_after":54900,"derivative":{"underlying":"Common Stock","underlying_shares":54900},"source":{"system":"sec-edgar","filing":"0001437749-20-020635","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920020635/rdgdoc.xml","form_type":"4"}},{"id":3018805,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-02T00:29:21.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":67400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.\tThe shares underlying the options will vest in 18 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over an 18-month period beginning September 30, 2020."}],"balance_after":67400,"derivative":{"exercise_price":0.91,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":67400},"source":{"system":"sec-edgar","filing":"0001437749-20-020635","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920020635/rdgdoc.xml","form_type":"4"}}]}